Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Suzanne Hendrix
1:31
Efficient use of open label extension data
Suzanne Hendrix
• 19 Jul 2023
4:29
Time saved with Alzheimer’s disease therapeutics
Suzanne Hendrix
• 19 Jul 2023
0:49
Time saved in Alzheimer’s disease in Phase III trial of donanemab
Suzanne Hendrix
• 19 Jul 2023
1:16
Measuring cognitive impairment in early Alzheimer’s disease
Suzanne Hendrix
• 19 Jul 2023
2:34
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease
Suzanne Hendrix
• 21 Mar 2023
3:48
The power of composite tests to track Alzheimer’s disease progression
Suzanne Hendrix
• 21 Mar 2023
3:25
Trends in the use of surrogate biomarkers during clinical trials
Suzanne Hendrix
• 21 Mar 2023
1:39
Futility analysis in clinical trials: practical and ethical considerations
Suzanne Hendrix
• 21 Mar 2023
0:59
Symptomatic versus disease modifying treatments
Suzanne Hendrix
• 21 Mar 2023
2:46
Distinguishing between disease modifying and symptomatic effects in clinical trials
Suzanne Hendrix
• 21 Mar 2023